Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.09. | Notice of Extraordinary General Meeting in PMD Device Solutions AB | 153 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / September 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The shareholders of PMD Device Solutions AB (publ), reg. no. 556639-6809 (the "Company"), are hereby invited... ► Artikel lesen | |
17.09. | PMD Device Solutions' RespiraSense Technology Demonstrates Capability in Predicting 7-Day Mortality | 190 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / September 17, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (Ticker Symbol:PMDS), a leader in digital healthcare technology, today announced... ► Artikel lesen | |
11.09. | PMD Device Solutions: PMDS Secures New Contract in the Western United States, Accelerating Path to Profitability | 266 | ACCESSWIRE | STOCKHOLM, SE / ACCESSWIRE / September 11, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (Ticker Symbol: PMDS), a leader in Digital Healthcare, is pleased to announce the signing... ► Artikel lesen | |
05.09. | PMD Device Solutions Secures Significant Sales Contract, Setting the Stage for Significant Growth in the US | 215 | ACCESSWIRE | STOCKHOLM, SE / ACCESSWIRE / September 5, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (Ticker Symbol: PMDS), a leader in Digital Healthcare, is excited to announce a significant... ► Artikel lesen | |
22.08. | PMD Device Solutions: Q2 Interim Report April-June 2024 | 192 | ACCESSWIRE | STOCKHOLM, SE / ACCESSWIRE / August 22, 2024 / PMD Device Solutions (FRA:8T0) (STO:PMDS) Press release: Stockholm, 22 August 2024. PMD Device Solutions AB's (PMDS) interim report for April - June 2024... ► Artikel lesen | |
15.08. | PMD Device Solutions: PMDS preliminary P&L results ahead of Q2 Interim Report | 249 | ACCESSWIRE | STOCKHOLM, SE / ACCESSWIRE / August 15, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) Financial information April - June 2024 (figures in brackets relate to the same period in Q2 2023). These are... ► Artikel lesen | |
13.08. | XFRA CAPITAL ADJUSTMENT INFORMATION - 13.08.2024 | 295 | Xetra Newsboard | Das Instrument EEMU IE00BMDBMX02 INVESCOM2 EMU ESG UNI SCR ETF wird cum Kapitalmassnahme gehandelt am 13.08.2024 und ex Kapitalmassnahme am 14.08.2024 The instrument EEMU IE00BMDBMX02 INVESCOM2 EMU... ► Artikel lesen | |
28.06. | PMD Device Solutions: Bulletin from the 2024 Annual General Meeting of PMD | 395 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / June 28, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The Annual General Meeting of PMD Device Solutions AB (publ), reg. no 556639-6809 (the "Company") was held today... ► Artikel lesen | |
25.06. | PMD Device Solutions Increases Financial Target with 160% to 260m SEK by YE 2026 | 243 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / June 25, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS) today announced it has revised its annual recurring revenue (ARR) target from 100m... ► Artikel lesen | |
28.05. | PMD Device Solutions: Q1 Interim Report January-March 2024 | 540 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / May 28, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) Press release: Stockholm, 28 May 2024. PMD Device Solutions AB's (PMDS) interim report for January - March 2024... ► Artikel lesen | |
27.05. | PMD Device Solutions AB Postpones the Annual General Meeting | 428 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / May 27, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (publ) cancels the annual general meeting due to administrative reasons and hereby convenes... ► Artikel lesen | |
13.05. | PMD Device Solutions Signs Letter of Intent for the Coala-Life Technology for 2 MSEK Per Year with Royalties | 328 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / May 13, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) On May 13th, PMD Device Solutions (PMDS) signed a Letter of Intent with Red Line Microconsult AB's CEO, Magnus... ► Artikel lesen | |
02.05. | PMD Device Solutions Agrees on Head of Terms to License the Coala-Life Technology | 404 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / May 2, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS) is evaluating the licensing of the Coala-Life technology and its associated intellectual... ► Artikel lesen | |
26.04. | Notice Of Annual General Meeting in PMD Device Solutions AB | 577 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The shareholders of PMD Device Solutions AB (publ), reg. no. 556639-6809 (the "Company") are hereby invited... ► Artikel lesen | |
26.04. | PMD Device Solutions Publishes 2023 Annual Report | 319 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS) announces today that the company's annual report for 2023 is published and available... ► Artikel lesen | |
11.04. | PMD Device Solutions Signs Transfer Agreement for Key Assets in Coala-Life Group AB to Accelerate its US Market Entry | 490 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 11, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) ("PMDS") today announced it has signed a transfer agreement with the Trustee of Coala-Life Group AB ("Coala... ► Artikel lesen | |
11.04. | Update to Closure Date for the Transfer Agreement Between PMD Device Solutions and Coala-Life Group AB | 345 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 11, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMDS and the Trustee of Coala-Life Group AB Estate will extend the closing date to April 12th.PMDS and the... ► Artikel lesen | |
09.04. | PMD Device Solutions Intends to Acquire Key Assets in Coala-Life Group AB to Accelerate its US Market Entry | 556 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 9, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions ("PMDS") today announced it intends to enter a transfer agreement with the Trustee of Coala-Life... ► Artikel lesen | |
03.04. | Bulletin from the Extraordinary General Meeting of PMD Device Solutions AB held on 3 April 2024 | 395 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 3, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (publ), held an extraordinary general meeting on Wednesday, 3 April 2024. The main resolutions... ► Artikel lesen | |
28.03. | PMD Device Solutions: Rett Syndrome Research Trust selects PMD Solutions' RespiraSense In Their Upcoming US-Based Biosensor Validation Study - VIBRANT | 273 | ACCESSWIRE | STOCKHOLM, SE / ACCESSWIRE / March 28, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) Rett Syndrome Research Trust (RSRT) is proud to announce its partnership with PMD Solutions (PMDS). RSRT's upcoming... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 51,82 | -0,96 % | Infineon, Siemens Healthineers, Rheinmetall, Heidelberg Materials: DAX-Ausblick | Der DAX (WKN: 846900) bleibt auf Rekordjagd. In der abgelaufenen Woche gelang der Ausbruch über die 19.000-Punkte-Marke. Das größte deutsche Börsenbarometer legte unter dem Strich mehr als 750 Punkte... ► Artikel lesen | |
FRESENIUS | 33,920 | -0,12 % | EQS-News: Formycon AG: Formycon und Fresenius Kabi erhalten FDA-Zulassung für FYB202/ OtulfiTM (Ustekinumab-aauz) | EQS-News: Formycon AG
/ Schlagwort(e): Zulassungsgenehmigung/Markteinführung
Formycon und Fresenius Kabi erhalten FDA-Zulassung für FYB202/ OtulfiTM (Ustekinumab-aauz)
30.09.2024... ► Artikel lesen | |
GERRESHEIMER | 79,10 | +3,20 % | Gerresheimer Aktie: Analysten sehen Potenzial trotz Kursrückgang | Die Gerresheimer-Aktie erlebte kürzlich einen deutlichen Einbruch, nachdem das Unternehmen seine Jahresprognose nach unten korrigiert hatte. Der Kurs fiel am Montag um etwa 18% und setzte den Abwärtstrend... ► Artikel lesen | |
CARL ZEISS MEDITEC | 69,05 | +3,14 % | Carl Zeiss Meditec Aktie: Kursrückgang trotz stabiler Prognosen | ||
FRESENIUS MEDICAL CARE | 37,790 | +0,05 % | Neue 10,50% Aktienanleihe mit Barriere auf Fresenius Medical Care in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC37J41/ WKN VC37J4) mit Barriere auf die Aktie von Fresenius... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 72,66 | -2,22 % | Jim Cramer Prefers Intuitive Surgical, Inc. (NASDAQ:ISRG) Over Procept Biorobotics | ||
GENEDX | 49,820 | +5,73 % | GeneDx to Participate in Fall Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall:... ► Artikel lesen | |
RXSIGHT | 48,900 | +2,19 % | Stifel hält an Kaufempfehlung für RxSight-Aktien angesichts des Wachstums fest | ||
TEMPUS AI | 52,94 | +8,13 % | Cathie Wood's ARK buys Tempus AI stock, sells Roku | ||
BRIGHTSPRING HEALTH SERVICES | 14,760 | +0,27 % | BrightSpring Health stock bullish as specialty medication trends strengthen-BTIG | ||
ECKERT & ZIEGLER | 41,840 | -0,24 % | DAX-Check: Adesso, Adidas, Aroundtown, BMW, Eckert & Ziegler, Gea Group, Renk, Rheinmetall, Traton | In dieser Woche will es bisher noch nicht so richtig laufen für den DAX. Gestern sah es lange Zeit nach Gewinnen aus. Am Nachmittag rutschte der DAX in die Gewinnzone. Heute muss er mit gemischten Vorgaben... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 6,910 | +0,73 % | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2024 Results | SCOTTSDALE, Ariz., Aug. 08, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
GOODRX | 7,090 | +3,05 % | GoodRx behält Buy-Rating mit konstantem Kursziel von TD Cowen | ||
PROGYNY | 16,305 | +3,07 % | KeyBanc hält an Sector Weight-Bewertung für Progyny-Aktien angesichts des Wettbewerbs fest | ||
PRIVIA HEALTH GROUP | 17,590 | +1,38 % | Privia Health's SWOT analysis: stock's resilience amid healthcare challenges |